Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC

Abdulmalik A. Bokhari(University of Gothenburg), Ganesh Umapathy(University of Gothenburg)
Lung Cancer
July 25, 2022
Cited by 11


Related Papers

No related papers found

Powered by citation graph analysis